mRNA and the Future of Biotechnology with Hannu Rajaniemi, Founder and CEO of Helix Nanotechnologies Curiosity

In this episode, Immad and Raj discuss biotechnology with Hannu Rajaniemi, Founder and CEO of Helix Nanotechnologies. Hannu shares the potential of mRNA as a platform for various applications, including lab-grown meat, cancer treatment, and customized vaccines. Hannu’s broad thinking and ability to tie biotech to social impact make for an engaging conversation that highlights the exciting potential of mRNA technology.
Follow the Curiosity Podcast on:

Instagram: https://www.instagram.com/curiositypod101/ 

TikTok: https://www.tiktok.com/@curiosity_podcast101?is_from_webapp=1&sender_device=pc 

YouTube: https://www.youtube.com/@CuriosityPodcast 

Substack: https://curiositypodcast.substack.com/

Timestamps:

00:02:02 Intro
00:08:52 Nanorobotics and future possibilities
00:11:05 Modeling Biological functions
00:16:04 AI design for immunotherapy
00:22:02 Protein synthesis process
00:26:29 Turning cells into protein factories
00:30:00 mRNA modifications and antiviral sensors
00:32:24 mRNA manufacturing and IP disputes
00:36:26 Liquid biopsies for early cancer detection
00:40:24 Using mRNA for cultured meat
00:45:09 Protein structure prediction
00:49:05 Evolution of SARS-CoV-2
00:52:19 The deadliness of viruses
00:55:55 mRNA wearable and global immune system
01:02:26 Storing information through viruses
01:04:07 Exponential technology and genetics